What impact will EPPO's new resistance risk assessment guideline have on selection pressure in the European Union?

被引:1
|
作者
Leonard, PK
Dutton, R
机构
[1] BASF AG, B-1180 Brussels, Belgium
[2] DowAgrosci Ltd, Abingdon OX14 4RN, Oxon, England
关键词
resistance; risk analysis; EPPO; guideline; Europe; cost;
D O I
10.1002/ps.563
中图分类号
S3 [农学(农艺学)];
学科分类号
0901 ;
摘要
This paper examines practical and regulatory implications, including both costs and benefits, resulting from implementation of EPPO's new resistance risk analysis guideline. Crop-protection companies operating in Europe are preparing risk analyses and management strategies, and are monitoring for resistance. However, this is a complex and expensive process involving technical, commercial and regulatory functions. The actual cost of filling these data gaps is consequently greater than many would have anticipated. The agrochemical industry has a vested interest in managing resistance and is committed to maintaining the essential contribution of crop-protection products to sustainable agriculture. However, with increasing regulatory costs, it is important that regulatory authorities concentrate requirements for resistance risk analyses, management strategies and monitoring where these are most needed. Should these requirements be applied indiscriminately, crop-protection companies will have to consider whether or not it is economically justifiable to make these investments, or whether to remove less profitable uses from product labels. In such situations, minor crops stand to be disproportionately effected. One year after publication, it is too early to measure the guideline's impact on selection pressure. It is already clear that the guideline represents an unprecedented step forward in the regulation and harmonisation of resistance management. There are, however, valid arguments against regulation of resistance management. One of the most important criticisms that is levelled against the latter approach is that, with the best motivation and with appropriate use restrictions on labels, these actions alone do not solve the problem. It is critical that all stakeholders in the crop protection process are made aware of the importance of resistance management and of complying with prescribed strategies. (C) 2002 Society of Chemical Industry.
引用
收藏
页码:939 / 943
页数:5
相关论文
共 50 条
  • [31] Update of the AWMF S2k Guideline "Diagnostics and Assessment of Occupational Asbestos-Related Diseases" - What's New?
    Kraus, T.
    Teschler, H.
    PNEUMOLOGIE, 2021, 75 (03): : 201 - 205
  • [32] Impact Assessment as Agenda-Setting: Procedural Politicking and the Mobilization of Bias in the European Union's Audiovisual Media Services Directive
    Brooks, Eleanor
    Lauber, Kathrin
    REGULATION & GOVERNANCE, 2025,
  • [33] Driver-Pressure-State-Impact-Response (DPSIR) Analysis and Risk Assessment for Soil Compaction-A European Perspective
    Schjonning, Per
    van den Akker, Jan J. H.
    Keller, Thomas
    Greve, Mogens H.
    Lamande, Mathieu
    Simojoki, Asko
    Stettler, Matthias
    Arvidsson, Johan
    Breuning-Madsen, Henrik
    ADVANCES IN AGRONOMY, VOL 133, 2015, 133 : 183 - 237
  • [34] The 2023 European Society of Hypertension guidelines for high blood pressure - What's new on diagnostic and therapeutic approaches
    Grassi, Guido
    Kreutz, Reinhold
    Mancia, Giuseppe
    PHARMACOLOGICAL RESEARCH, 2024, 199
  • [35] Risk Assessment or Risk Acceptance: An Activist's Perspective on Why the EPA's Attempts to Achieve Environmental Justice Have Failed and What They Can Do About It
    Canales, Suzie
    Ozymy, Joshua
    Jarrell, Melissa Lee
    ENVIRONMENTAL JUSTICE, 2012, 5 (01) : 59 - 62
  • [36] What impact does the new urbanization in China's Yangtze River economic belt have on the ecological environment?
    Ke, Xiaoling
    Min, Yuanyuan
    Guo, Haixiang
    Wang, Deyun
    Mougharbel, Amal
    ENVIRONMENT DEVELOPMENT AND SUSTAINABILITY, 2023, 26 (10) : 26679 - 26698
  • [37] KDIGO (Kidney Disease: Improving Global Outcomes) Guideline Update On The Management Of Blood Pressure In Chronic Kidney Disease: What's New And What's Different From Other Guidelines
    Cheung, Alfred
    Chang, Tara, I
    Cushman, William
    Furth, Susan
    Hou, Fan Fan
    Ix, Joachim H.
    Knoll, Gregory
    Muntner, Paul
    Pecoits-Filho, Roberto
    Sarnak, Mark J.
    Tobe, Sheldon W.
    Tomson, Charles
    Mann, Johannes
    HYPERTENSION, 2021, 78
  • [38] What is different for people with MS who have pressure ulcers: A reflective study of the impact upon people's quality of life?
    McGinnis, Elizabeth
    Nelson, E. Andrea
    Gorecki, Claudia
    Nixon, Jane
    JOURNAL OF TISSUE VIABILITY, 2015, 24 (03) : 83 - 90
  • [39] The European Union's New USB-C Standardization Amendment: What Does it Mean for Innovation Within the Consumer Technology Industry?
    Fourneaux, Adrien
    NORTHWESTERN JOURNAL OF INTERNATIONAL LAW & BUSINESS, 2024, 44 (01):
  • [40] Multi-risk instruments for emergency response: a multi-hazard and multi-risk assessment of the European Union's Solidarity and Emergency Aid Reserve
    Hochrainer-Stigler, Stefan
    Trogrlic, Robert Sakic
    Reiter, Karina
    DISASTERS, 2025, 49 (01)